Vanderbilt Institute for Infection Immunology and Inflammation (VI4)

Zinc deficiency promotes Acinetobacter lung infection: study

The study findings point to the potential of interleukin-13 antibodies — approved for use in humans — as a treatment to protect against bacterial pneumonia in patients with zinc deficiency.

Chenyu Zhu takes a look at tardigrades, or water bears, through a microscope. (photo by Erin O. Smith)

MEGAMicrobe 2024 photo gallery

Scientists from Vanderbilt University and Vanderbilt University Medical Center led several activities to illustrate the important roles that microorganisms play in the environment and human health.

Graduate student Chiamaka Okoye shows Nora Tidwell, 6, and Avah Floyd, 7, how the gastrointestinal bacterium H. pylori swims through stomach mucus by having them dip their gloved hands into a tub of slime and dried pasta.

MEGAMicrobe event for children set for Saturday, Oct. 26

The seventh annual event invites students to conduct science experiments, join in hands-on activities, and win prizes and giveaways.

color-enhanced cross section of tumor tissue

New Video: Study shows cancer vaccine blocks tumor progression at early lesion stage

Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study.
The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.

Bacterial metabolism plays role in staph antibiotic tolerance

Staph is a leading bacterial cause of death from bloodstream, bone and joint infections, in part because of high rates of antibiotic treatment failure.

Cover of the VI4 AiR (Artist-in-Residence) 2022 annual report: B cells, antibodies and strands of free-flowing DNA represent B cell genome modification and the formation of unique antibodies. Illustration by Nadia Kafil, a UT-Austin biochemistry major who participated in the nationwide AiR program in the lab of Columbia University professor Uttiya Basu, PhD.

Vanderbilt Vaccine Center to begin artist-in-residence program this fall

The six-month-long “Visualizing Virology” residency is an extension of the VI4 Artist-in-Residence Program established in 2019 by the Vanderbilt Institute for Infection, Immunology and Inflammation (VI4), and supported by the Burroughs Wellcome Fund.

1 2 3 5